<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="189">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05158686</url>
  </required_header>
  <id_info>
    <org_study_id>ICICOR-IMPROVED-RECTO-2021</org_study_id>
    <nct_id>NCT05158686</nct_id>
  </id_info>
  <brief_title>Use of Drug-Coated Balloon to Improve Recanalization of a Coronary Chronic Total Occlusion After Failed Angioplasty</brief_title>
  <acronym>IMPROVED-RECTO</acronym>
  <official_title>Use of Drug-Coated Balloon to Improve Recanalization of a Coronary Chronic Total Occlusion After Failed Angioplasty: The IMPROVED-RECTO Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ignacio J. Amat Santos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Clínico Universitario de Valladolid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational retrospective registry to compare effectiveness of paclitaxel-coated vs. non&#xD;
      coated balloon angioplasty proximal to a Chronic Total Occlussion (CTO) after failed&#xD;
      revascularization. Primary objective is to determine success rate after repeated percutaneous&#xD;
      coronary intervention of a CTO 3 to 6 months after paclitaxel-coated balloon angioplasty&#xD;
      proximal to the persistent lesion.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Actual">October 1, 2021</completion_date>
  <primary_completion_date type="Actual">October 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Success of repeated percutaneous coronary intervention of a CTO 3 to 6 months after balloon angioplasty proximal to the persistent lesion.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality after second attempt of CTO recanalization</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessed by EQ5D questionnaire</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural duration during second attempt</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation during second attempt</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast administration during second attempt</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Events at 1-year follow-up</measure>
    <time_frame>1 year</time_frame>
    <description>All events including: Death, stroke, myocardial infarction (MI), target lesion revascularization (TLR), and contrast-induced nephropathy (CIN)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">44</enrollment>
  <condition>Chronic Total Occlusion</condition>
  <arm_group>
    <arm_group_label>Paclitaxel-coated balloon angioplasty</arm_group_label>
    <description>Patients with previous failed recanalization of a CTO treated with paclitaxel coated balloon immediately proximal to the CTO during the index procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-coated balloon angioplasty</arm_group_label>
    <description>Patients with previous failed recanalization of a CTO treated with non-coated balloon immediately proximal to the CTO during the index procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Paclitaxel-coated Balloon dilation angioplasty</intervention_name>
    <description>Paclitaxel-coated ballon dilation angioplasty proximal to CTO lesion after failed percutaneous recanalization</description>
    <arm_group_label>Paclitaxel-coated balloon angioplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-coated Balloon dilation angioplasty</intervention_name>
    <description>Non-coated ballon dilation angioplasty proximal to CTO lesion after failed percutaneous recanalization</description>
    <arm_group_label>Non-coated balloon angioplasty</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with coronary angiography in which percutaneous coronary intervention results in&#xD;
        failure during treatment of a CTO. Indication of the procedures will be clinically driven.&#xD;
        Informed consent will be provided after the first failed attempt of CTO recanalization.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Failed recanalization of a CTO in patients with clinical indication for the&#xD;
             percutaneous procedure.&#xD;
&#xD;
          -  Patient willing to participate in the study providing signed informed consent.&#xD;
&#xD;
          -  J-CTO Score ≥2.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Unfeasible recanalization of the CTO according to the interventional cardiologists of the&#xD;
        center.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>December 2, 2021</study_first_submitted>
  <study_first_submitted_qc>December 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 15, 2021</study_first_posted>
  <last_update_submitted>December 2, 2021</last_update_submitted>
  <last_update_submitted_qc>December 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clínico Universitario de Valladolid</investigator_affiliation>
    <investigator_full_name>Ignacio J. Amat Santos</investigator_full_name>
    <investigator_title>Coordinator of Interventional Cardiology Unit</investigator_title>
  </responsible_party>
  <keyword>Repeated procedure, Angioplasty, Paclitaxel, drug-coated balloon</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

